Prosecution Insights
Last updated: July 17, 2026

Ivc Patent Agency

6 pending office actions • 4 clients • 5 examiners • 5 art units • 0 of 6 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Quality Metrics (n=339 apps, methodology: how we score firms)

89.4%
Allowance Rate
n=339
+0.69σ
Allowance Rate (norm)
n=339
2.1
OAs to Allowance
n=270
-0.72σ
OAs to Allow (norm)
n=270
763 days
Time to Allowance
n=270
-3.2pp
Interview Lift
n=339
11.9%
RCE Rate
n=339
0.0%
Appeal Rate
n=339

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=6 (min 20)
76.5%
§102 Overcome
n=34
86.1%
§103 Overcome
n=115
90.3%
§112 Overcome
n=31

Specialization & Scale

A61B, E21B, F41A
Top CPC Subclasses
25%
Top-3 CPC Share
n=339
0
Practitioners
n=339
Apps / Practitioner
n=339 (min 20)

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
3
Medium (50%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (33%)
§103 only1 (17%)
§102 only2 (33%)
Double-patenting only1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
17% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
83% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KALIHER, HANS CHRISTIAN 2 61.8% +29.6%
MILLER, SERENITY A 1 70.1% +32.8%
PAGANO, ALEXANDER R 1 79.0% +11.4%
ELDRED, JOHN W 1 77.6% +7.9%
WEISBERGER, RICHARD C 1 47.7% -4.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18296723 SYSTEM AND METHODS FOR ASSESSING THE VALUE OF EQUITY IN MULTIPLE PROPERTIES, ESTABLISHING LOAN TERMS, AND FACILITATING THE PROCESS OF A TRADE-IN MORTGAGE WEISBERGER, RICHARD C 70d overdue
18839364 Compositions and Methods for the Treatment of Sexual Dysfunctions PAGANO, ALEXANDER R 26d

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18839364 Compositions and Methods for the Treatment of Sexual Dysfunctions PAGANO, ALEXANDER R 26d
19439318 APPARATUS FOR DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY MILLER, SERENITY A
19054364 DEVICE, SYSTEM AND METHOD FOR INTERMITTENT DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY KALIHER, HANS CHRISTIAN
19053677 DEVICE, SYSTEM AND METHOD FOR INTERMITTENT DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY KALIHER, HANS CHRISTIAN

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
37812
37711
16921
36411
36931

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19439318 APPARATUS FOR DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY Everett Medical Technologies LLC MILLER, SERENITY A 3771 DP Final Rejection Pending Jan 03, 2026
19054364 DEVICE, SYSTEM AND METHOD FOR INTERMITTENT DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY Everett Medical Technologies LLC KALIHER, HANS CHRISTIAN 3781 §102 Final Rejection Pending Feb 14, 2025
19053677 DEVICE, SYSTEM AND METHOD FOR INTERMITTENT DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY Everett Medical Technologies LLC KALIHER, HANS CHRISTIAN 3781 §103 Non-Final OA Pending Feb 14, 2025
18839364 Compositions and Methods for the Treatment of Sexual Dysfunctions The Jonathan Hurt Living Trust PAGANO, ALEXANDER R 1692 §101 Non-Final OA 26d Pending Aug 16, 2024
18607673 BOLT CARRIER MOVEMENT MECHANISM PROVIDING PRIMARY EXTRACTION FORCE MULTIPLICATION, FIREARMS COMPRISING SAME, KITS FOR CONSTRUCTING FIREARMS COMPRISING SAME, AND BOLT CARRIER GROUPS FOR ENABLING SAME Ares Defense Systems, Inc. ELDRED, JOHN W 3641 §102 Non-Final OA 73d overdue Pending Mar 18, 2024
18296723 SYSTEM AND METHODS FOR ASSESSING THE VALUE OF EQUITY IN MULTIPLE PROPERTIES, ESTABLISHING LOAN TERMS, AND FACILITATING THE PROCESS OF A TRADE-IN MORTGAGE Calque, Inc. WEISBERGER, RICHARD C 3693 §101 Final Rejection 70d overdue Pending Apr 06, 2023

Managing Ivc Patent Agency's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month